The genetic material of the HIV virus is encased in multiple structures that hide it from the host immune system. The capsid, in blue, protects the virus after it enters a cell and shuttles it to ...
More than 20 years ago, the U.S. became the leader in the worldwide fight against HIV/AIDS. The Bush administration ...
2024 — Researchers conducted a breakthrough proof-of-concept study that found an HIV-like virus particle that could cease the need for lifelong ... Long-Acting Injectable Cabotegravir for HIV ...
In the Virus-Like Particle Translational Oncology Laboratory, Qizhi Cathy Yao, M.D., Ph.D. is developing non-infectious HIV virus-like particles (VLPs) as candidate HIV mucosal vaccines for both ...
They graphically represent the life cycle of HIV-1, from the initial binding of the viral particle onto a host cell (Viral Entry), through insinuation into the host cell's nucleus to spark the ...
The development of an effective HIV vaccine remains an urgent public health need due to the high genetic variability and rapid mutation rates of the virus, which limit the generation of broadly ...
If you're worried about HIV infection, you may wonder whether it's safe to have oral sex. While it's not risk-free, the chances of spreading the virus that causes AIDS are very low if you take the ...
Hosted on MSN1mon
‘Pivotal step’: University of Utah biochemist’s HIV research contributes to Science’s ‘Breakthrough of the Year’laid the foundation for the development of a highly effective, long-lasting prophylactic — or preventive measure — against HIV, the virus that causes AIDS. The resulting drug — lenacapavir ...
A technique invented by the lab, known as Electron Microscopy-Based Polyclonal Epitope Mapping (EMPEM), lets the researchers see exactly where on the HIV virus antibodies bind. When they carried ...
A technique invented by the lab, known as Electron Microscopy-Based Polyclonal Epitope Mapping (EMPEM), lets the researchers see exactly where on the HIV virus antibodies bind. When they carried ...
Hosted on MSN10mon
Possible HIV cure 1 step closer to human trials: Ontario researchers“We acquired blood samples and applied our HIV virus-like particle, or HLP for short,” Ho says. “One other thing we're looking for is if our HLP, after we apply it to the immune ...
In contrast, lentiviruses such as human immunodeficiency virus (HIV) do not depend on host cell mitosis to access the nucleus. As a consequence, lentviruses are able to replicate within non ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback